End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making

Dose-adjusted-EPOCH-R obviates the need for radiotherapy in most patients with primary mediastinal B-cell lymphoma. End-of-treatment PET, however, does not accurately identify patients at risk of treatment failure, thereby confounding clinical decision making. To define the role of PET in primary me...

Descripción completa

Detalles Bibliográficos
Autores principales: Melani, Christopher, Advani, Ranjana, Roschewski, Mark, Walters, Kelsey M., Chen, Clara C., Baratto, Lucia, Ahlman, Mark A., Miljkovic, Milos D., Steinberg, Seth M., Lam, Jessica, Shovlin, Margaret, Dunleavy, Kieron, Pittaluga, Stefania, Jaffe, Elaine S., Wilson, Wyndham H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068044/
https://www.ncbi.nlm.nih.gov/pubmed/29748435
http://dx.doi.org/10.3324/haematol.2018.192492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068044/
https://www.ncbi.nlm.nih.gov/pubmed/29748435
http://dx.doi.org/10.3324/haematol.2018.192492

Ejemplares similares